Starling Oncology, Inc. (STLN) Stock Ticker
STLN right now
Market factors today
Unlock the full STLN picture
About Starling Oncology, Inc.
Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.
STLN stock facts
| Ticker symbol | STLN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
| Market cap | $665.9M |
| CEO | Daniel Virnich |
| Employees | 641 |
| Headquarters | Cerritos, CA, US |
| IPO date | 2026-08-04 |
| Website | www.starlingoncology.com |
What you can see for STLN on Tickr
Live STLN price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the STLN report.
Rankings
FAQ
What is the ticker symbol for Starling Oncology, Inc.?
The ticker symbol for Starling Oncology, Inc. is STLN, listed on the NASDAQ.
What is STLN?
Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across…